XML 28 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Derivative Financial Instruments
6 Months Ended
Jun. 30, 2017
Derivative Financial Instruments [Abstract]  
Derivative Financial Instruments

Note 7. Derivative Financial Instruments



Risk Management Objective of Using Derivatives



The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of its known or expected cash payments principally related to its borrowings.



Derivative Instruments



The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate caps as part of its interest rate risk management strategy. Interest rate caps involve the receipt of variable amounts from a counterparty at the end of each period in which the interest rate exceeds the agreed fixed price. The Company does not use derivatives for trading or speculative purposes. The Company requires that hedging derivative instruments be highly effective in reducing the risk exposure that they are designated to hedge. As a result, there is no significant ineffectiveness from any of its derivative activities. 



The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. Derivatives that are not designated as hedges must be adjusted to fair value through earnings. For a derivative that is designated and that qualifies as a cash flow hedge, the effective portion of the change in fair value of the derivative is initially recorded in accumulated other comprehensive income (loss) (“AOCI”). Amounts recorded in AOCI are subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of a derivative’s change in fair value is immediately recognized in earnings.



As of June 30, 2017, the Company had three interest rate caps to hedge the variable cash flows associated with its existing $150.0 million of variable-rate term loans. The caps have a notional value of $150.0 million and will effectively cap the annual interest rate payable at 4.0% plus 1.30% to 1.85%, depending on leverage, with respect to $50.0 million for the period from December 1, 2014 (effective date) to May 1, 2021, $50.0 million for the period from September 1, 2015 (effective date) to April 1, 2019 and $50.0 million for the period from September 1, 2015 (effective date) to February 3, 2020. The Company is required to make certain monthly variable rate payments on the term loans, while the applicable counterparty is obligated to make certain monthly floating rate payments based on LIBOR to the Company in the event LIBOR is greater than 4.0%, referencing the same notional amount.



The Company records all derivative instruments on a gross basis in other assets on the consolidated balance sheets, and accordingly, there are no offsetting amounts that net assets against liabilities. The following table presents a summary of the Company’s derivative instruments designated as hedging instruments (dollars in thousands):





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

Fair Value

 

 

Notional Amount

Derivative Instrument

 

Effective Date

 

Maturity Date

 

Interest Rate Strike

 

 

June 30, 2017

 

 

December 31, 2016

 

 

June 30, 2017

 

 

December 31, 2016

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Cap

 

12/1/2014

 

5/1/2021

 

4.0% 

 

$

49 

 

$

204 

 

$

50,000 

 

$

50,000 

Interest Rate Cap

 

9/1/2015

 

4/1/2019

 

4.0% 

 

 

 

 

14 

 

 

50,000 

 

 

50,000 

Interest Rate Cap

 

9/1/2015

 

2/3/2020

 

4.0% 

 

 

 

 

63 

 

 

50,000 

 

 

50,000 

  Total

 

 

 

 

 

 

 

$

57 

 

$

281 

 

$

150,000 

 

$

150,000 



The effective portion of changes in the fair value of derivatives designated and qualified as cash flow hedges is recorded in AOCI and will be reclassified to interest expense in the period that the hedged forecasted transaction affects earnings on the Company’s variable rate debt. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings into interest expense.



The following table presents the effect of the Company's derivative financial instruments on its accompanying consolidated statements of operations for the three and six months ended June 30, 2017 and 2016 (in thousands):





 

 

 

 

 

 

 

 

 

 

 

 

 



 

For the Three Months Ended June 30,

 

For the Six Months Ended June 30,

 



 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Interest rate caps in cash flow hedging relationships:

 

 

 

 

 

 

 

 

 

 

 

 

 

Amount of gain recognized in AOCI on derivatives (effective portion)

 

$

16 

 

$

 -

 

$

34 

 

$

 -

 

Amount of gain reclassified from AOCI into interest expense (effective portion)

 

$

16 

 

$

 -

 

$

34 

 

$

 -

 



The Company estimates that approximately $0.2 million will be reclassified from AOCI as an increase to interest expense over the next twelve months.